Alan Bradley
Fondatore presso Kymab Group Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Yiu Ting Tsoi | M | 51 |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | - |
Len Blavatnik | M | 66 |
University of Cambridge
| - |
Feng Luo | M | 60 |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | - |
Eden Wong | M | 54 |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | - |
Xuan Sun | M | 48 |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | - |
Arjun K. Mathrani | M | 79 |
University of Cambridge
| - |
Arokia Nathan | M | - |
University of Cambridge
| - |
Onora Sylvia O'Neill | F | - |
University of Cambridge
| - |
Patrick Maxwell | M | 62 |
University of Cambridge
| - |
Keith Glover | M | - |
University of Cambridge
| 10 anni |
Val Livada | M | - |
University of Cambridge
| - |
David Hampton | M | - |
University of Cambridge
| - |
Shashank Singh | M | 48 |
University of Cambridge
| - |
Dame Alison F. Richard | M | - |
University of Cambridge
| - |
Bill Milne | M | - |
University of Cambridge
| - |
Peter Nolan | M | 75 |
University of Cambridge
| 45 anni |
Zeeshan Ali | M | - |
University of Cambridge
| - |
Frank Kelly | M | - |
University of Cambridge
| - |
Bradley Fried | M | 59 |
University of Cambridge
| - |
Tan Li | F | 60 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
José Lopez | M | 72 |
University of Cambridge
| - |
Nalin Satykam Kohli | M | - |
University of Cambridge
| - |
Douglas Christopher Patrick McDougall | M | 80 |
University of Cambridge
| - |
Sharon Flood | F | 59 |
University of Cambridge
| 5 anni |
Andrew Woods | M | - |
University of Cambridge
| - |
Peter Williamson | M | 67 |
University of Cambridge
| - |
Alasdair Coles | M | - |
University of Cambridge
| - |
Graham Blyth | M | 70 |
University of Cambridge
| - |
James Appleby | M | - |
University of Cambridge
| 6 anni |
Fiona Gilbert | F | - |
University of Cambridge
| - |
Samantha Lucy | F | - |
University of Cambridge
| - |
Bruce Beckles | M | - |
University of Cambridge
| - |
Clare Woodcraft-Scott | F | - |
University of Cambridge
| 4 anni |
Michael Joseph Kelly | M | 75 |
University of Cambridge
| - |
Priya Shah | F | - |
University of Cambridge
| 1 anni |
Stephen Leslie Barter | M | - |
University of Cambridge
| - |
Erwin Boos | M | 46 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
Brian A. Ference | M | - |
University of Cambridge
| - |
Simone Song | F | 59 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
Shankar Balasubramanian | M | - |
University of Cambridge
| - |
Timothy Nigel Carl Wells | M | 62 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
Ian Hugh White | M | - |
University of Cambridge
| - |
David Jaynee | M | 67 |
University of Cambridge
| 7 anni |
Christopher Gilligan | M | - |
University of Cambridge
| - |
William McDonnell | M | - |
University of Cambridge
| - |
Lynn Faith Gladden | F | 63 |
University of Cambridge
| - |
Haider Zameer Choudrey | M | 37 |
University of Cambridge
| - |
Chris Rider | M | - |
University of Cambridge
| - |
Roger A. Pedersen | M | - |
University of Cambridge
| - |
Sanaya Morawala-Patell | F | - |
University of Cambridge
| - |
Alan H. Windle | M | - |
University of Cambridge
| - |
Ashok Venkitaraman | M | - |
University of Cambridge
| - |
Stephen Jackson | M | 62 |
University of Cambridge
| - |
David Walker | M | 84 |
University of Cambridge
| - |
Jean-Philippe Tripet | M | 61 |
University of Cambridge
| - |
John Charles Shakeshaft | M | 70 |
University of Cambridge
| - |
Andrew Morgan | M | 68 |
University of Cambridge
| - |
Bruce Ponder | M | - |
University of Cambridge
| - |
Christopher Robin Lowe | M | 79 |
University of Cambridge
| - |
Elizabeth Peace | F | 72 |
University of Cambridge
| - |
John Leonard Eatwell | M | 79 |
University of Cambridge
| 54 anni |
Christian Itin | M | 59 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
Henning Sirringhaus | M | 59 |
University of Cambridge
| - |
Stephen Evans-Freke | M | 72 |
University of Cambridge
| - |
Ian J. Lewis | M | 63 |
University of Cambridge
| - |
John Campbell Robertson | M | 73 |
University of Cambridge
| 30 anni |
Khalid Yosif Abdulla-Janahi | M | - |
University of Cambridge
| - |
Sherry Coutu | F | 61 |
University of Cambridge
| - |
Andrew Cunningham | M | 68 |
University of Cambridge
| - |
David Glover | M | - |
University of Cambridge
| - |
Carol J. Hochman | F | 73 |
University of Cambridge
| - |
Charles Gordon Smith | M | - |
University of Cambridge
| - |
Andrew Hopper | M | 71 |
University of Cambridge
| - |
Timothy James Rink | M | 78 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | - |
Matthew Bullock | M | 75 |
University of Cambridge
| - |
Allan Bradley | M | 64 |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | 8 anni |
David Cebon | M | - |
University of Cambridge
| - |
Gregor Rozenberg | M | - |
University of Cambridge
| - |
Christopher Town | M | - |
University of Cambridge
| - |
Andrew D. Hall | M | - |
University of Cambridge
| - |
Nick Slaymaker | M | - |
University of Cambridge
| - |
Tat Chang | M | 56 |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | - |
Emma Rothschild | F | 76 |
University of Cambridge
| - |
Derek Robert McAuley | M | - |
University of Cambridge
| - |
Gus MacIver | M | - |
University of Cambridge
| - |
John Lee | M | 74 |
University of Cambridge
| - |
Bryan Rigg | M | - |
University of Cambridge
| - |
Stefanos Capsaskis | M | 66 |
University of Cambridge
| 7 anni |
Richard Friend | M | 71 |
University of Cambridge
| - |
Florin Udrea | M | - |
University of Cambridge
| - |
Gehan Anil Joseph Amaratunga | M | - |
University of Cambridge
| 28 anni |
James Gatheru Mathenge | M | - |
University of Cambridge
| - |
Richard V. Penty | M | - |
University of Cambridge
| 23 anni |
Samir I. Toubassy | M | - |
University of Cambridge
| - |
Jack Lang | M | - |
University of Cambridge
| - |
Nigel Slater | M | 70 |
University of Cambridge
| - |
Martin Rees | M | - |
University of Cambridge
| - |
James Augustus Henry Murray | M | 63 |
University of Cambridge
| - |
Anthony David Stalbow | M | 85 |
University of Cambridge
| - |
Nick Clarry, | - | - |
University of Cambridge
| 21 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 95 | 95.00% |
Isole Cayman | 5 | 5.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Alan Bradley
- Contatti personali